Health X Platform logo

Health X Platform financials and balance sheet

NSE: HEALTHXBSE: 533259Healthcare ServicesSmall Cap

Formerly Sastasundar Ventures
Last close ₹266.80down ₹2.05 (0.76%)BSE ₹261.90

Share price at the NSE close on 23 Oct 2026. Previous close ₹268.85.

52-week range of traded prices to 23 Oct 2026
₹252.50Low, 30 Mar 2026₹363.00High, 13 Jan 2026
Market cap
₹849 Cr1,526th largest listed
P/E
Lossover the last 12 months
P/B
1.3
Dividend yield
Nonein the last 12 months
ROE
−3.1%
ROCE
−9.4%
Debt to equity
0.03
Volume, NSE
7,88571.6% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Health X Platform annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 8 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out.

The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹159 Cr, differs from its quarters added, ₹165 Cr.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,319
  2. Materials and goods−1,208
  3. Employee costs−84
  4. Other expenses−79
  5. Operating profit−52
  6. Depreciation−6.6
  7. Other income+58
  8. One-off items−1.1
  9. Finance costs−0.8
  10. Profit before tax−2.4
  11. Tax+0.9
  12. Net profit−1.4

What the company owns

  • Plant, investments and other assets₹753 Cr
  • Inventory₹145 Cr
  • Cash and bank₹30 Cr
  • Receivables₹8 Cr

What pays for it: net worth and liabilities

  • Net worth₹765 Cr
  • Other liabilities₹148 Cr
  • Borrowings₹22 Cr

Health X Platform business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Consolidated, ₹ crore, as the company reports them. A segment at a loss has no share of profit.Health X Platform segment results by quarter

Revenue by segment

₹1,319 CrTotal
  • Healthcare Network₹1,283 Cr97.3% of total
  • Others₹23 Cr1.7% of total
  • Financial Services₹13 Cr1.0% of total

Profit by segment

  • Others₹1.0 Cr8.2% of total
  • Financial Services₹10.7 Cr91.8% of total

Segment results by year

Consolidated, ₹ crore, years to March.

  • Healthcare Network

    Revenue, ₹ crore
    Profit, ₹ crore
  • Others

    Revenue, ₹ crore
    Profit, ₹ crore
  • Financial Services

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses2193855486311,0401,3761,1111,319
Company revenue, as in its results2193855486311,0401,3761,1111,319
Revenue2133825406231,0391,3551,0881,283
Revenue growth–79.2%41.3%15.4%66.8%30.4%−19.7%17.9%
Profit−34−44−231,096−139−19−259−67
Margin−16.0%−11.6%−4.2%175.9%−13.4%−1.4%−23.8%−5.2%
Return on capital−32.2%−31.8%−15.8%99.3%−15.5%−2.1%−36.0%−11.0%
Assets1221851921,1731,1071,025825771
Liabilities16464868210143104163
Capital employed1061391441,104897881721608
Revenue–––––––23
Revenue31881212313
Revenue22––––––
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Consolidated, ₹ crore, years to March.Health X Platform quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 28 MayMar 2020Filed 3 JulMar 2021Filed 23 JunMar 2022Filed 13 JunMar 2023Filed 25 JulMar 2024Filed 19 JulMar 2025Filed 30 MayMar 2026Filed 30 May
Revenue from operations1331592193855486311,0401,3761,1111,319
155175–4415626801,0841,3701,1671,371
Materials and goods bought1091401993674925829601,2331,0171,208
Employee costs25––28294445495084
Other expenses22––454154788810079
Operating profit before depreciation−22−15–−55−14−49−445−56−52
Operating margin−16.8%−9.7%–−14.4%−2.6%−7.7%−4.2%0.4%−5.0%−4.0%
Materials, % of revenue81.8%––95.2%89.8%92.2%92.4%89.6%91.6%91.6%
Employee costs, % of revenue18.7%––7.4%5.3%7.0%4.4%3.6%4.5%6.4%
Other expenses, % of revenue16.4%––11.8%7.5%8.5%7.5%6.4%9.0%6.0%
Depreciation and amortisation76–5448967
Operating profit after depreciation−29−21–−60−19−53−52−4−62−59
Other income432331224606058
Finance costs3121121101
Profit before one-off items and tax−28−19−43−58−16−43−2956−2−1
One-off items07–001,157−80−191−1
Profit before tax−28−12−43−58−161,115−3756−193−2
12–−51131−23−36−70−1
Share of profit of joint ventures and associates–––––−5−85−86−11–
−29−12−38−52−17978−996−134−1
Other comprehensive income–––000−1002
Total comprehensive income–––−52−17978−1016−1341
Net margin−21.5%−7.5%−17.6%−13.5%−3.1%154.9%−9.6%0.4%−12.0%−0.1%
Net margin without joint ventures and associates–––––155.8%−1.4%6.7%−11.0%–
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank. Tax is left blank for the year to Mar 2019: profit before tax less the tax charge stated does not come to the profit after tax the same statement states, so the tax charge is not shown. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2019: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 28 MayMar 2020Filed 3 JulMar 2021Filed 23 JunMar 2022Filed 13 JunMar 2023Filed 25 JulMar 2024Filed 19 JulMar 2025Filed 30 MayMar 2026Filed 30 May
2002462291,2079941,000865765
142210200908753762670641
Share capital–32323232323232
Reserves–178168876722731638609
Belonging to outside owners of subsidiaries583629299240237195124
Borrowings0510000022
Total assets2283162931,2781,2061,150974936
Plant in use, after depreciation11660575768726378
Plant being built–00010101
Inventories337777114181116110145
Trade receivables81514213543108
Cash and cash equivalents717121332341230
Other bank balances0111991631500
Current investments14–––––––
Net debt−21−13−3−212−195−49−12−8
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 23 JunMar 2022Filed 13 JunMar 2023Filed 25 JulMar 2024Filed 19 JulMar 2025Filed 30 MayMar 2026Filed 30 May
Cash from operations−31−331−10438−17−74
Capital spending1528141015
Free cash flow−31−336−13224−28−89
Cash from investing21343124−34−1171
Cash from financing4−11−1−20−80
Dividends paid000000
Shares bought back000000
Shares issued000000
Net change in cash−51192−1918
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Health X Platform dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 28 MayMar 2020Filed 3 JulMar 2021Filed 23 JunMar 2022Filed 13 JunMar 2023Filed 25 JulMar 2024Filed 19 JulMar 2025Filed 30 MayMar 2026Filed 30 May
Earnings per share−₹9.00−₹3.73−₹12.06−₹12.20−₹3.27₹222.73−₹22.70₹2.79−₹28.66₹0.37
Diluted earnings per share−₹9.00−₹3.73−₹11.59−₹12.20−₹3.27₹222.73−₹22.70₹2.79−₹28.66₹0.37
Book value per share––₹44.67₹66.05₹62.84₹285.50₹236.84₹239.66₹210.58₹201.47
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)3173453821853711,139702966771817

Ratios

Consolidated, years to March.Health X Platform PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 28 MayMar 2020Filed 3 JulMar 2021Filed 23 JunMar 2022Filed 13 JunMar 2023Filed 25 JulMar 2024Filed 19 JulMar 2025Filed 30 MayMar 2026Filed 30 May
Revenue growth54.1%–37.1%76.4%42.2%15.2%64.7%32.3%−19.2%18.8%
––−27.0%−22.0%−5.1%127.9%−8.7%1.2%−12.7%0.2%
–––5.0 pts17.0 pts133.0 pts−136.6 pts9.9 pts−13.9 pts12.9 pts
From the net margin–––11.5 pts17.9 pts305.1 pts−135.8 pts9.5 pts−16.1 pts12.9 pts
From asset turnover–––−7.4 pts−1.1 pts−166.2 pts−0.3 pts0.3 pts1.6 pts0.0 pts
From borrowing–––0.9 pts0.2 pts−6.0 pts−0.5 pts0.0 pts0.6 pts0.0 pts
Return on capital employed–––−24.0%−7.8%−4.4%−5.2%−0.4%−7.2%−7.5%
Cash conversion–––––−33.8%–652.1%––
Debt to equity––0.000.020.040.000.000.000.000.03
Receivable days––1314912121132
Inventory days––6077577169344044
Asset turnover––0.961.421.800.800.841.171.051.38
Assets per rupee of net worth––1.601.541.481.421.491.551.481.46
Sales per rupee of plant––1.896.409.5811.0515.2619.2117.5316.88
Capital spending to depreciation––––0.221.143.411.561.782.26
Plant being built, % of plant in use–––0.0%0.1%0.7%1.5%0.5%16.2%1.5%
Interest cover is left blank for the years to Mar 2017, Mar 2018, Mar 2020, Mar 2021, Mar 2022, Mar 2023, Mar 2024, Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. Revenue growth is left blank for the year to Mar 2018: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
0.1%
Measure10 years5 years3 years
Revenue growth, yearly rate31.4%19.2%8.3%
Return on equity, average–21.6%−3.8%
Return on capital employed, average–−4.9%−5.0%
Operating margin, average−7.1%−4.1%−2.9%
Net margin, average7.0%26.7%−3.9%
Asset turnover, average–1.051.20
Debt to equity, average–0.010.01

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−488−53−74
Cash from investing604136171
Cash from financing−95−82−80
Capital spending724015
Dividends paid000
Shares bought back000
Shares issued for cash000

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–−2.62123.02−9.590.14−10.84−10.35
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––−0.54−0.45––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points52.64−34.1028.83−5.61−64.3312.7212.37
Assets under construction, years of additionsOur threshold 2 years of additions–0.050.100.050.03–0.06
Effective tax ratePublished threshold 17.16 per cent––11.76–−65.29––
Tax charged less tax paid, % of profitOur threshold 10 percentage points––1.64–−76.23––
A threshold marked as ours has no published figure; it is the line we read the check against.